RLMDRELMADA THERAPEUTICS, INC.vs its industry peers
A metric-by-metric comparison of RELMADA THERAPEUTICS, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RLMDThis | $451M#8 | — | 2.2x#7 | 87869.0x#10 | -35.4%#8 | — | -1152275.3%#10 | 0.0%#2 | — | — | — | — |
| EOLS | $528M#1 | — | — | 1.8x#2 | 11.6%#5 | -2.4%#8 | -11.0%#2 | — | -40.5%#2 | 4#1 | 22.8%#3 | — |
| OVID | $522M#2 | — | 2.5x#8 | 72.0x#9 | 1181.3%#1 | 34.1%#2 | -585.2%#8 | -8.3%#4 | — | — | — | — |
| ASMB | $518M#3 | 20.5x#3 | 1.7x#4 | 7.2x#6 | 153.5%#3 | 84.8%#1 | -16.8%#3 | -2.0%#3 | -4.4%#1 | — | 24.0%#2 | — |
| CAPR | $498M#4 | — | 2.0x#5 | — | -100.0%#11 | -159.6%#13 | — | -42.7%#6 | — | — | 37.6%#1 | — |
| MPLT | $486M#5 | 0.2x#1 | 1.4x#2 | — | — | -107.7%#12 | — | -46.3%#7 | — | — | — | — |
| PBYI | $485M#6 | 18.4x#2 | 3.5x#11 | 2.1x#3 | -0.9%#6 | 2.8%#7 | 16.3%#1 | 22.5%#1 | — | — | — | — |
| IRD | $452M#7 | — | — | 31.8x#7 | 29.1%#4 | 13.8%#4 | -271.9%#7 | — | — | — | — | — |
| ARCT | $443M#9 | — | 2.6x#9 | 5.4x#5 | -46.1%#9 | 18.7%#3 | -93.0%#5 | -38.3%#5 | -136.2%#3 | — | — | — |
| PRTA | $423M#10 | — | 1.5x#3 | 43.6x#8 | -92.8%#10 | -99.6%#10 | -2216.4%#9 | -85.1%#10 | — | — | — | — |
| SPRY | $414M#11 | — | 33.1x#12 | 4.9x#4 | -5.5%#7 | -2241.8%#14 | -212.9%#6 | -1369.1%#13 | -177.6%#4 | — | — | — |
| AVIR | $413M#12 | — | 2.0x#6 | 1.2x#1 | 622.5%#2 | 6.0%#6 | -51.5%#4 | -77.4%#9 | — | — | — | — |
| LRMR | $410M#13 | — | 3.2x#10 | — | — | -105.5%#11 | — | -130.1%#11 | -350.3%#5 | — | — | — |
| TTRX | $409M#14 | — | 595.0x#13 | — | — | -80.6%#9 | — | -465.0%#12 | — | — | — | — |
| RCKT | $384M#15 | — | 1.0x#1 | — | — | 13.8%#5 | — | -60.5%#8 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice